WIA
BIIB icon

Wealthedge Investment Advisors’s Biogen BIIB Stock Holding History

Wealthedge Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,873
Closed -$530K – 152
2025
Q1 		$530K Buy
3,873
+2,139
+123% +$306K 0.24% 86
2024
Q4 		$265K Buy
+1,734
New +$292K 0.12% 129

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wealthedge Investment Advisors's BIIB Position: Q2 2025 in Review

Wealthedge Investment Advisors sold out of Biogen (BIIB) in Q2 2025, closing a stake of 3,873 shares — an estimated $530K sold.

Wealthedge Investment Advisors first reported a position in BIIB in Q4 2024 and held it in 2 quarters. The position peaked at $530K in Q1 2025. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • Wealthedge Investment Advisors reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
  • Wealthedge Investment Advisors sold 3,873 Biogen shares in Q2 2025, an estimated $530K.
  • Wealthedge Investment Advisors first reported a position in Biogen in Q4 2024 and held it in 2 quarters.
  • Wealthedge Investment Advisors's Biogen position peaked at $530K in Q1 2025.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Wealthedge Investment Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.